<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huber HF</submitter><funding>National Institutes of Health</funding><pagination>1012</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8539335</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(10)</volume><pubmed_abstract>The emergence of SARS-CoV-2 variants is cause for concern, because these may become resistant to current vaccines and antiviral drugs in development. Current drugs target viral proteins, resulting in a critical need for RNA-targeted nanomedicines. To address this, a comparative analysis of SARS-CoV-2 variants was performed. Several highly conserved sites were identified, of which the most noteworthy is a partial homopurine palindrome site with >99% conservation within the coding region. This sequence was compared among recently emerged, highly infectious SARS-CoV-2 variants. Conservation of the site was maintained among these emerging variants, further contributing to its potential as a regulatory target site for SARS-CoV-2. RNAfold was used to predict the structures of the highly conserve</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates.</pubmed_title><pmcid>PMC8539335</pmcid><funding_grant_id>T35OD029981</funding_grant_id><pubmed_authors>Huber HF</pubmed_authors><pubmed_authors>Delong RK</pubmed_authors><pubmed_authors>Millagaha Gedara NI</pubmed_authors><pubmed_authors>Nava-Chavez J</pubmed_authors><pubmed_authors>Jaberi-Douraki M</pubmed_authors><pubmed_authors>DeVader S</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Aparicio-Lopez C</pubmed_authors><pubmed_authors>Gaudreault NN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates.</name><description>The emergence of SARS-CoV-2 variants is cause for concern, because these may become resistant to current vaccines and antiviral drugs in development. Current drugs target viral proteins, resulting in a critical need for RNA-targeted nanomedicines. To address this, a comparative analysis of SARS-CoV-2 variants was performed. Several highly conserved sites were identified, of which the most noteworthy is a partial homopurine palindrome site with >99% conservation within the coding region. This sequence was compared among recently emerged, highly infectious SARS-CoV-2 variants. Conservation of the site was maintained among these emerging variants, further contributing to its potential as a regulatory target site for SARS-CoV-2. RNAfold was used to predict the structures of the highly conserve</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-06-13T03:23:21.746Z</modification><creation>2025-02-19T03:53:22.724Z</creation></dates><accession>S-EPMC8539335</accession><cross_references><pubmed>34681236</pubmed><doi>10.3390/ph14101012</doi></cross_references></HashMap>